去年，AngioDynamics Inc表现最佳的业务板块Endovascular Therapies实现营收160.93M美元。United States的营收贡献最高，去年达到250.98M美元。最近一个季度，截至2022-05-31，AngioDynamics Inc表现最佳的业务板块Endovascular Therapies实现营收41.48M美元。United States的营收贡献最高，达到73.59M美元。

业务

营业收入

占比

年报

年报

单季报

Endovascular Therapies

Vascular Access

Oncology/Surgery

Vascular Interventions & Therapies

FY2022

FY2021

FY2020

Endovascular Therapies

160.93M(50.89%)

121.43M(41.73%)

98.97M(37.46%)

Vascular Access

100.19M(31.68%)

101.31M(34.81%)

94.30M(35.70%)

Oncology/Surgery

55.10M(17.42%)

54.62M(18.77%)

57.15M(21.64%)

Vascular Interventions & Therapies

--(--)

13.65M(4.69%)

13.74M(5.20%)

地区

营业收入

占比

年报

年报

单季报

United States

International

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

United States

250.98M(85.81%)

251.49M(82.75%)

282.71M(83.46%)

265.96M(84.11%)

237.04M(81.46%)

207.98M(78.73%)

216.96M(80.17%)

International

41.52M(14.19%)

52.43M(17.25%)

56.04M(16.54%)

50.26M(15.89%)

53.97M(18.54%)

56.18M(21.27%)

53.68M(19.83%)